- Home
- GRFS vs DOO Comparison
GRFS vs DOO Comparison
Compare GRFS & DOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRFS | DOO |
|---|---|---|
| Founded | 1940 | 1937 |
| Country | Spain | Canada |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GRFS | DOO |
|---|---|---|
| Price | $8.05 | $64.60 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $10.15 | ★ $75.00 |
| AVG Volume (30 Days) | ★ 722.1K | 178.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.77% | 0.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.50 | $6.07 |
| P/E Ratio | ★ $18.67 | $338.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.19 | $62.57 |
| 52 Week High | $11.14 | $81.89 |
Technical Indicators
Market Signals| Indicator | GRFS | DOO |
|---|---|---|
| Relative Strength Index (RSI) | 33.92 | 30.77 |
| Support Level | $7.64 | $62.57 |
| Resistance Level | $9.11 | $81.52 |
| Average True Range (ATR) | 0.28 | 2.38 |
| MACD | -0.09 | -0.75 |
| Stochastic Oscillator | 16.55 | 14.25 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.